Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cytogen Corp.

Division of EUSA Pharma
www.cytogen.com

Latest From Cytogen Corp.

EUSA Pharma Aims To Grow Through Acquisitions In Specialty Rx Market

EUSA Pharma announced the launch of operations March 23 with a group of products acquired from Jazz Pharmaceuticals and funding from equity investor Essex Woodlands; it is the third specialty pharma company set up by U.K. entrepreneur Bryan Morton.

BioPharmaceutical Europe

Jazz Enters Oncology Market With EUSA Acquisition

Jazz strays away from its CNS focus with a $700 million acquisition of EUSA Pharma, adding the specialty pharma’s oncology product to its portfolio.

BioPharmaceutical Business Strategies

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2008

Highlights from the Q1 2008 review of pharmaceutical and biotechnology dealmaking: there was a drought in biopharma financings--particularly from the public markets with only two completed IPOs--but VC funding was strong and made up 40% of the total. M&A activity was also down and saw only one multi-billion dollar deal. In alliances, oligonucleotides were the subject of seven biopharmaceutical collaborations and accounted for most of the quarter's dealmaking money.
BioPharmaceutical

Start-Up Quarterly Statistics, Q1 2008

Start-Up analyzes fundraising and alliances among start-ups in the biopharmaceutical, medical device and in vitro diagnostics segments from January through March 2008. Data comes from Windhover’s Strategic Transactions Database.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Medical Devices
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • EUSA Pharma
  • Senior Management
  • Kevin G Lokay, Pres. & CEO
    Kevin Bratton, SVP, Fin. & CFO
    Stephen A Ross, SVP, Sales & Mktg.
  • Contact Info
  • Cytogen Corp.
    Phone: (609) 750-8200
    650 College Rd. East
    Ste. 3100
    Princeton, NJ 08540
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register